# Bupivacaine 0.125% Versus Bupivacaine 0.25% in Superficial Cervical Plexus Block for Tympanomastoid Surgeries in Adults

> **NCT06381401** · PHASE4 · RECRUITING · sponsor: **Cairo University** · enrollment: 60 (estimated)

## Conditions studied

- Surgical Field
- Acute Postoperative Pain

## Interventions

- **DRUG:** bupivacaine 0.25%
- **DRUG:** bupivacaine 0.125%

## Key facts

- **NCT ID:** NCT06381401
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-07-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381401, "Bupivacaine 0.125% Versus Bupivacaine 0.25% in Superficial Cervical Plexus Block for Tympanomastoid Surgeries in Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06381401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*